Zhongguancun announced that its subsidiary Duoduo Pharmaceutical's application for registration and marketing of drugs produced in China was accepted by the State Drug Administration. The acceptance numbers are CYHS2602214 and CYHS2602213, and the registration classification is 4 types of chemicals. As of August 31, 2026, the project has invested a total of 4.9738 million yuan in R&D expenses, and has now entered the review stage.

Zhitongcaijing · 2d ago
Zhongguancun announced that its subsidiary Duoduo Pharmaceutical's application for registration and marketing of drugs produced in China was accepted by the State Drug Administration. The acceptance numbers are CYHS2602214 and CYHS2602213, and the registration classification is 4 types of chemicals. As of August 31, 2026, the project has invested a total of 4.9738 million yuan in R&D expenses, and has now entered the review stage.